DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021 Visit Post
2 Cybersecurity in Healthcare: Major Threats and Challenges Visit Post
3 Analyzing the Key Trends Driving the Biosimilar Market Growth Visit Post
4 Insights into some of the Biosimilar Drugs that are approved and launched in 2021 Visit Post
5 Evaluating the Essential Factors Building the Value-Based Healthcare Model Visit Post
6 Social Determinants of Health and their Impact on COVID-19 Visit Post
7 An Insight Into the Weight Loss and Obesity Market Visit Post
8 Smart Hospital: How it is Shaping the Future of Healthcare Delivery Visit Post
9 Which Countries Top the Chart in Global Pharmaceutical Market? Visit Post
10 Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies Visit Post
11 Analysing the Treatment Approaches in the Hearing Loss Market and Key Companies in the Domain Visit Post
12 Analyzing the Key Opportunities & Challenges in the Nutraceuticals Market Visit Post
13 Analyzing the Emerging Demand for the Probiotics Visit Post
14 Healthcare Data Breach: What it Means for Companies and the Consumer? Visit Post
15 How Healthcare Apps are Adding New Perspectives to the Healthcare Industry? Visit Post
16 Analyzing the Prospects of Drones in Healthcare Delivery System Visit Post
17 New Approaches and Evolutions to Reshape the Diabetes Management and Care Visit Post
18 Technological Innovation: The Medicine of Healthcare Visit Post
19 Mounting Prevalence of Neurological Disorders and the Key Companies Bidding to Solve the Riddle Visit Post
20 Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics Market Visit Post
21 Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Major Pharma Companies Visit Post
22 Key Pharma Companies Expanding their Arm in the Skin Cancer Segment Visit Post
23 Charting out the COVID-19 Vaccine Landscape Visit Post
24 Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products Visit Post
25 Does the use of Assistive Technologies in Autism Spectrum Disorder Payoff? Visit Post
26 How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market Visit Post
27 Migraine Market: How Pharma Companies are trying to Uncomplicate the Disease and Bring in Novel Therapies Visit Post
28 Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth Visit Post
29 Alarming Growth of Chronic Respiratory Diseases (CRDs) and Their Prolonged Impact on the Quality of Life Visit Post
30 The Rising Burden of Substance Use Disorder And The Treatment Scenario Visit Post
31 Asthma: Rising Prevalence And The Key Challenges In The Management Visit Post
32 How Is Osteoporosis Impacting The Quality Of Life? Visit Post
33 Understanding The Increasing Prevalence Of Diabetes And Its Complications Visit Post
34 Which Pharma Companies are Working to Mitigate the Burden of Digestive Disorders? Visit Post
35 Sleep Disorders: An Emerging Public Health Issue Visit Post
36 How Depression Is Eroding The Mental And The Physical Health Of The Society? Visit Post
37 How Fitness Trackers Are Shaping the Future of Healthcare? Visit Post
38 Bleeding Disorders: How Key Companies Are Shaping The Bleeding Disorders Therapeutics Market? Visit Post
39 Diagnosing At-Home: Are At-Home Diagnostic Tools The New Trends? Visit Post
40 Applications of AI in Healthcare: COVID-19 and Beyond Visit Post
41 How Robots Are Introducing A New Dimension To Healthcare Service Delivery Visit Post
42 Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered Visit Post
43 Progeria: The Rarest Case of Premature Ageing Visit Post
44 Why Empathy Is More Important Today In Corporate Culture Than Ever? Visit Post
45 Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization Visit Post
46 Eating Disorders: What Happens When Stigma And Misconceptions Command The Health Visit Post
47 The Burden And The Impact Of Mental Health Issues In Today’s Time Visit Post
48 The Obesity Pandemic: What can we do about it? Visit Post
49 Medical Tourism: Road to Affordable and Quality Medical Care Visit Post
50 Alcohol Use Disorder (AUD): When Drinking Becomes A Headache Visit Post
51 8 Of The Most Common Foods Allergies - Do You Have One? Visit Post
52 A Globally Rising Burden of Sexually Transmitted Diseases (STDs) Visit Post
53 Will Wearable Devices be Streamlined in Healthcare? Visit Post
54 Bioterrorism: A Threat To The Healthcare And Global Peace Visit Post
55 Lung Cancer and its Increasing Global Burden Visit Post
56 Is Subscription Model Going to be the New Normal for Healthcare Industry? Visit Post
57 How Will Artificial Intelligence Change The Future Of Healthcare? Visit Post
58 Adding Value to the Health with a Value-Based Healthcare Model Visit Post
59 Understanding The Disparities In The Healthcare Sector Visit Post
60 How do we curb the Opioid Epidemic? Visit Post
61 Charting Out the Key Drivers and Barriers Influencing Telehealth Adoption in Healthcare Visit Post
62 How Are Chatbots Improving Healthcare Service Delivery? Visit Post
63 The State of Alternative Medicine In The Healthcare Visit Post
64 Healthcare Delivery System: What lies in the future? Visit Post
65 Social Determinants of Health Goes Beyond Just Healthcare Visit Post
66 Nutrition Intervention: Foods to take and foods to avoid when suffering from Gastroparesis Visit Post
67 Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference Visit Post
68 Merck; Bayer; Shionogi set to showcase their candidates indicated for Chronic RefractoryCough in the ATS Virtual Conference Visit Post
69 Recognising The Warning Signs Of ADHD Visit Post
70 In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player Visit Post
71 What are the Top Five Leading Causes of Deaths in the World? Visit Post
72 The Most Promising COVID-19 Vaccine Candidates In The Pipeline To Watch Out For Visit Post
73 Can Alzheimer's be cured with Marijuana? Visit Post
74 The Question That Remains Unanswered: What Might Be Causing Alzheimer’s? Visit Post
75 What are the 10 early signs of Alzheimer’s that are overlooked? Visit Post
76 Will there be a second wave of coronavirus? Visit Post
77 Potential Diagnostic solutions that may significantly contribute to COVID-19 detection Visit Post
78 Cardiovascular Disease: A major cause of health loss and a global burden Visit Post
79 Potential of Digital therapeutics and increasing CVDs Visit Post
80 Polypills: Can they offer a potential approach to treat CVDs? Visit Post
81 National Influenza Vaccination Week Visit Post
82 Novel treatment approval promises a better future for Sickle cell disease patients Visit Post
83 Antimicrobial resistance crisis: A global need for antibiotic awareness Visit Post
84 Beta-Thalassemia Pharmacological Therapies Visit Post
85 Non-small cell lung cancer emerging therapies Visit Post
86 The growing size of Sanfilippo syndrome Market: Drivers and Barriers Visit Post
87 Geographic Atrophy Treatment Market: Novel Therapies to Enter the Market Visit Post
88 Biogen seeks the FDA approval to revive its Alzheimer’s drug Aducanumab Visit Post
89 Incyte Corporation submits positive results of trials for its drug Ruxolitinib in GvHD Visit Post
90 Global Burden of Liver cancer: Is it rising?  Visit Post
91 Batten Disease Market: Barriers and Growth Opportunities Visit Post
92 Cystic Fibrosis Drug Market: Emerging drugs that may improve lung infections Visit Post
93 Hyperthyroidism Treatment Market and Drugs Visit Post
94 FDA approves Ibsrela to reduce the global burden of Irritable Bowel Syndrome Visit Post
95 Driving factors boosting the Hepatocellular Carcinoma Market Visit Post
96 FDA approves Non-Controlled treatment for Excessive Daytime Sleepiness Visit Post
97 HIV Treatment Landscape and A New Approach Visit Post
98 Frightening Surge in HIV-drug Resistance: The Biggest Challenge Ahead Visit Post
99 Idiopathic Pulmonary Fibrosis Market Landscape and Forecast Visit Post
100 Is it Okay to take Antibiotics without a prescription? Visit Post
101 Is Parainfluenza virus contagious? Visit Post
102 EMDR Therapy- Is it really that good? Visit Post
103 Teplizumab delays the progression of Type 1 Diabetes Visit Post
104 Lilly overtakes rivals with its Cluster Headache approval Visit Post
105 Origins of the depressive behaviour in Huntington's disease Visit Post
106 Meet the World's most expensive drug: Zolgensma Visit Post
107 Off-label therapies dominate NASH Market Share Visit Post
108 Beware! Season of Lyme has come Visit Post
109 Antitrypsin Deficiency Pipeline Visit Post
110 European Commission gives a nod to Zynquista for type 1 diabetes in adults Visit Post
111 Can Spinal Muscular Atrophy be treated by Protease Inhibitors? Visit Post
112 The promising Pipeline for Gene Therapy In Oncology Visit Post
113 Alzheimer's drug fails! Is it time to move on? Visit Post
114 Japan has got new ways to treat corneas Visit Post
115 Welcome the Slumber Visit Post
116 FDA just lost a gem as Scott Gottlieb resigns Visit Post
117 A helping hand in treatment of CRC Visit Post
118 CRISPR proves to be a blessing for LASSA fever Visit Post
119 The antidepressant drug gets support from FDA Visit Post
120 Relation between gut microbes and depression bolstered Visit Post
121 ‘Software’ differences between humans and monkeys Visit Post
122 Virtual Reality Maps Helps Doctors Understand Cancer Tumor Structure Visit Post
123 Highly mutated cancers respond better to immune therapy Visit Post
124 Triple Negative Breast Cancer Responds to TINAGL Therapy Visit Post
125 Machine Learning Models to Help Predicting Cancer Symptoms, Plan Treatment Visit Post
126 How Neanderthal DNA might have shaped some human brains Visit Post
127 66 Year Ohio Woman Becomes Cancer Free, Thanks to CAR T Cell Therapy Visit Post
128 Now, Artificial Intelligence to Accurately Identify Cancer Cells Visit Post
129 Gold Nanoparticles May Soon Treat Prostate Cancer Visit Post
130 Cancer Cells Trick Body’s Immunity to Survive against Treatment Visit Post
131 Breakthrough Device Designation granted to the AI Software for CTEPH Visit Post
132 Scientists Now Target Attacking Evolution Process of Cancer Cells Visit Post
133 Sleeping at Workplaces: Re-energizing Formula or OSA Disease? Visit Post
134 Chemotherapy as a treatment for Cancer?  Visit Post
135 Virus, the Cancer Therapy of the Future Visit Post
136 150 Year Old Drug Indicates Potential of Future Cancer Therapy Visit Post
137 The risk of solid cancer after chemotherapy Visit Post
138 Drugmakers will now have to reveal medicine prices in television ads Visit Post
139 Is Gene Therapy the Next Cancer Treatment Revolution?  Visit Post
140 The novel therapy for brain cancer treatments Visit Post
141 Antidepressants withdrawal hits millions of people Visit Post
142 Companion Diagnostics Visit Post
143 Researchers Turn towards Light to Solve Lung Cancer Puzzle Visit Post
144 Snippet Visit Post
145 Pancreatic Cancer Treatment to Stride Beyond Chemotherapy Visit Post
146 Snippet Visit Post
147 Now, Nanoparticles for Cancer Treatment Visit Post
148 SNIPPET Visit Post
149 Orphan Drug Act and Its Criticism Visit Post
150 Snippet Visit Post
151 Snippet Visit Post
152 Snippet : Genetic Mutation Visit Post
153 Snippet : Migraine Visit Post
154 Snippets : Parkinson Visit Post
155 Snippet : Endometriosis Visit Post
156 Snippet : Acute lymphoblastic leukemia Visit Post
157 Predicting risk of Acute Myeloid Leukemia (AML) in healthy individuals Visit Post
158 Parkinson's and tuberculosis shares a common protein that could provide better drugs for both Visit Post
159 Potential cure for Common cold Visit Post
160 Takeda buys Shire in a deal worth USD 62 billion Visit Post
161 Takeda acquisition on Shire raises its share by 25 percent Visit Post
162 New method for classification of CNS tumors Visit Post
163 Cholesterol drug Praluent successful in reducing heart risk Visit Post
164 Snippet: M&A activities of big pharma’s will fuel CAR-T cell therapy Visit Post
165 Gilead Sciences  launched a highly effective hepatitis C drug Sovaldi Visit Post
166 In vivo monitoring of T cell–dendritic cell interactions by intercellular enzymatic labelling Visit Post
167 Snippet Visit Post
168 Snippet Visit Post
169 Ketamine to work in mice Visit Post
170 Chemists may help solve the air-pollution health crisis Visit Post
171 'Killer' Mosquito to be released in 20 US states to fight mosquitoes Visit Post
172 Publishers collaborate to remove journal articles from ResearchGate Visit Post
173 South Korean researchers influencing lift of human-embryo restrictions Visit Post
174 Cancer Globally (Vol. 1, Issue 1) Visit Post
175 Reprogrammed cells relieve Parkinson's symptoms in trials Visit Post
176 Social Behavior Loss Observed in Gene-edited ants through CRISPR Visit Post
177 Genetically Engineered Salmon : Are you up for dinner? Visit Post
178 Innovate the UK, aiming to drive efforts to commercialize research Visit Post
179 Georgia physician to lead US public-health agency Visit Post
180 Elsevier Granted millions in damages from Sci-Hub by US Court Visit Post
181 China cracks down on fake peer reviews Visit Post
182 New cancer drug tested in mice may benefit certain leukaemia patients Visit Post
183 Gut bacteria can stop cancer drugs from working Visit Post
184 Bio-manufacturing with Spider Silk for pre-term babies Visit Post
185 FDA grants accelerated approval to pembrolizumab Visit Post
186 Geneticists enlist engineered virus & CRISPR to battle citrus disease Visit Post
187 Scientists relieved by Emmanuel Macron’s French election victory Visit Post
188 World Ovarian Cancer Day Visit Post
189 Science wins reprieve in US budget deal Visit Post
190 Cord Blood makes brains of elderly mice young again Visit Post
191 The Snippet: Targeting metabolism in Renal Cell Carcinoma Visit Post
192 Whitepaper: Impact of Brexit on Pharma Space Visit Post
193 CRISPR finds faults in previous researches Visit Post
194 A Probiotic drink from the gut microbiome of an elite athlete Visit Post
195 DNA typos to blame for most Cancer Mutations Visit Post
196 South Korea’s scientists seek change amid political chaos Visit Post
197 New biomarkers improve standard screening in Pancreatic Cancer Visit Post
198 New biomarkers for screening in Pancreatic Cancer Visit Post
199 The Snippet - What Trump’s new travel ban means for science? Visit Post
200 Antibiotic Resistance: The Big Challenge of Healthcare Industry Visit Post
201 Hepatitis C drugs re-energize global fight over patents Visit Post
202 The Snippet: Delay in hiring science advisers intensifies Brexit worries Visit Post
203 Diminishing pipeline of Galectin Inhibitors Visit Post
204 TRAIL Receptor Agonists: Emerging target therapies against Cancer Visit Post
205 OncoTrack develops new biomarkers for colon cancer Visit Post
206 Familial Adenomatous Polyposis (FAP): A cataclysmic genetic mutation Visit Post
207 Chronic Kidney Disease: Complex Debilitating Condition Visit Post
208 Clinical trials need to assess drug efficacy before trials Visit Post
209 Chronic Obstructive Pulmonary Disorder Visit Post
210 Statistical Insight on Some Common Cancers Visit Post
211 Can the brain detect Addictive cravings even after death? Visit Post
212 BioAsia 2017 Visit Post
213 Happy Republic Day !!! Visit Post
214 Subtypes of cervical cancer identified Visit Post
215 Prostate Cancer: Metastases leading to increased incidence in the USA Visit Post
216 Warm Wishes for Lohri Visit Post
217 Pulling the apoptotic trigger for necrosis Visit Post
218 Fatal French clinical trial failed to check data before raising dose Visit Post
219 Warm Greetings from DelveInsight! Visit Post
220 DelveInsight's Discount on Market Research Reports! Visit Post
221 Merry Christmas Visit Post
222 Pharma M&A Rebound May Take a While in 2017 Visit Post
223 US drug approvals plummet in 2016 Visit Post
224 Anterior Uveitis: A Vision-threatening condition Visit Post
225 Mexico's Human-Embryo Research on Tenterhooks Visit Post
226 The next generation of 'weaponized antibody' therapies Visit Post
227 NgAgo gene-editing, claiming to be a better alternative to CRISPR gene editing, falls into a controversy in peer-reviewed papers Visit Post
228 Hurry Up! Grab the latest discount offer... Visit Post
229 CRISPR gene-editing tested in a person for the first time Visit Post
230 Donald Trump's US election win stuns scientists Visit Post
231 Meet DelveInsight in BioEurope '16 Visit Post
232 DelveInsight Wishes you a Prosperous Diwali! Visit Post
233 Autism study finds early intervention has lasting effects Visit Post
234 Do we need to revise human genetics? Visit Post
235 The Global M&A Frenzy Drops in the 3rd Quarter Visit Post
236 The Snippet: The Success of Cannabidiol Visit Post
237 Merck Focuses its Research on Hard to Treat Cancers Visit Post
238 FDA Approves Sarepta’s Muscular Dystrophy Drug after Months of Debate Visit Post
239 PI3Kγ- a molecular switch that controls immune suppression Visit Post
240 HER2 Expression and its Dynamic Functional States Visit Post
241 Novel Genetics Biomarker found by a Group of Researchers May Offer Novel Treatment Approach for Cancer Visit Post
242 AstraZeneca’s new Asthma Drug Aces Phase III trial Visit Post
243 Identity Crises Faced by a Venerable Brain-Cancer Cell Line Visit Post
244 The Road Less Travelled: EpiPen's Pricing Policy Visit Post
245 Denali's Impressive Research Portfolio Visit Post
246 The Curious Case of CRISPR Technology Visit Post
247 Collaboration provides new insight into cancer treatment Visit Post
248 Turning your own skin cells into cancer-killing machines Visit Post
249 DelveInsight: One Year Anniversary! Visit Post
250 Delveinsight launched novel Drug Pipeline reports Visit Post
251 Successful Launch of Mechanism of Action Based Pipeline Reports Visit Post